vs

Side-by-side financial comparison of DBV Technologies S.A. (DBVT) and ELECTRO SENSORS INC (ELSE). Click either name above to swap in a different company.

DBV Technologies S.A. is the larger business by last-quarter revenue ($2.8M vs $2.8M, roughly 1.0× ELECTRO SENSORS INC). ELECTRO SENSORS INC runs the higher net margin — 3.7% vs -1195.5%, a 1199.3% gap on every dollar of revenue. On growth, DBV Technologies S.A. posted the faster year-over-year revenue change (158.8% vs 14.8%). Over the past eight quarters, DBV Technologies S.A.'s revenue compounded faster (12.4% CAGR vs 10.8%).

DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.

Polar Electro Oy is a Finnish manufacturer of sports training computers, particularly known for developing the world's first wireless heart rate monitor.

DBVT vs ELSE — Head-to-Head

Bigger by revenue
DBVT
DBVT
1.0× larger
DBVT
$2.8M
$2.8M
ELSE
Growing faster (revenue YoY)
DBVT
DBVT
+144.0% gap
DBVT
158.8%
14.8%
ELSE
Higher net margin
ELSE
ELSE
1199.3% more per $
ELSE
3.7%
-1195.5%
DBVT
Faster 2-yr revenue CAGR
DBVT
DBVT
Annualised
DBVT
12.4%
10.8%
ELSE

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
DBVT
DBVT
ELSE
ELSE
Revenue
$2.8M
$2.8M
Net Profit
$-33.2M
$103.0K
Gross Margin
50.3%
Operating Margin
-1235.7%
-0.3%
Net Margin
-1195.5%
3.7%
Revenue YoY
158.8%
14.8%
Net Profit YoY
-8.9%
-48.8%
EPS (diluted)
$-0.24
$0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DBVT
DBVT
ELSE
ELSE
Q4 25
$2.8M
Q3 25
$2.8M
$2.7M
Q2 25
$1.5M
$2.4M
Q1 25
$2.2M
Q4 24
$2.4M
Q3 24
$2.5M
Q2 24
$1.2M
$2.2M
Q1 24
$1.4M
$2.2M
Net Profit
DBVT
DBVT
ELSE
ELSE
Q4 25
$103.0K
Q3 25
$-33.2M
$208.0K
Q2 25
$-41.9M
$59.0K
Q1 25
$-64.0K
Q4 24
$201.0K
Q3 24
$238.0K
Q2 24
$-33.1M
$-4.0K
Q1 24
$-27.3M
$11.0K
Gross Margin
DBVT
DBVT
ELSE
ELSE
Q4 25
50.3%
Q3 25
53.1%
Q2 25
51.2%
Q1 25
48.4%
Q4 24
49.6%
Q3 24
50.4%
Q2 24
47.2%
Q1 24
48.1%
Operating Margin
DBVT
DBVT
ELSE
ELSE
Q4 25
-0.3%
Q3 25
-1235.7%
6.6%
Q2 25
-2806.2%
-0.1%
Q1 25
-7.5%
Q4 24
1.3%
Q3 24
6.9%
Q2 24
-2914.9%
-4.8%
Q1 24
-2029.7%
-4.5%
Net Margin
DBVT
DBVT
ELSE
ELSE
Q4 25
3.7%
Q3 25
-1195.5%
7.6%
Q2 25
-2858.4%
2.5%
Q1 25
-2.9%
Q4 24
8.4%
Q3 24
9.5%
Q2 24
-2852.4%
-0.2%
Q1 24
-1943.5%
0.5%
EPS (diluted)
DBVT
DBVT
ELSE
ELSE
Q4 25
$0.03
Q3 25
$-0.24
$0.06
Q2 25
$-0.31
$0.02
Q1 25
$-0.02
Q4 24
$0.06
Q3 24
$0.07
Q2 24
$-0.34
$0.00
Q1 24
$-0.28
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DBVT
DBVT
ELSE
ELSE
Cash + ST InvestmentsLiquidity on hand
$69.8M
$10.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$52.9M
$14.8M
Total Assets
$110.5M
$15.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DBVT
DBVT
ELSE
ELSE
Q4 25
$10.6M
Q3 25
$69.8M
$10.6M
Q2 25
$103.2M
$10.2M
Q1 25
$10.0M
Q4 24
$10.0M
Q3 24
$10.3M
Q2 24
$66.2M
$9.9M
Q1 24
$101.5M
$10.1M
Stockholders' Equity
DBVT
DBVT
ELSE
ELSE
Q4 25
$14.8M
Q3 25
$52.9M
$14.7M
Q2 25
$86.2M
$14.4M
Q1 25
$14.3M
Q4 24
$14.3M
Q3 24
$14.1M
Q2 24
$79.1M
$13.8M
Q1 24
$111.7M
$13.8M
Total Assets
DBVT
DBVT
ELSE
ELSE
Q4 25
$15.7M
Q3 25
$110.5M
$15.7M
Q2 25
$143.4M
$15.2M
Q1 25
$15.1M
Q4 24
$14.9M
Q3 24
$15.0M
Q2 24
$114.2M
$14.5M
Q1 24
$145.9M
$14.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DBVT
DBVT
ELSE
ELSE
Operating Cash FlowLast quarter
$-32.4M
$20.0K
Free Cash FlowOCF − Capex
$-32.6M
FCF MarginFCF / Revenue
-1173.5%
Capex IntensityCapex / Revenue
4.2%
Cash ConversionOCF / Net Profit
0.19×
TTM Free Cash FlowTrailing 4 quarters
$-138.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DBVT
DBVT
ELSE
ELSE
Q4 25
$20.0K
Q3 25
$-32.4M
$395.0K
Q2 25
$-33.9M
$277.0K
Q1 25
$-30.0K
Q4 24
$-277.0K
Q3 24
$362.0K
Q2 24
$-35.1M
$-158.0K
Q1 24
$-34.7M
$202.0K
Free Cash Flow
DBVT
DBVT
ELSE
ELSE
Q4 25
Q3 25
$-32.6M
$389.0K
Q2 25
$-33.9M
Q1 25
Q4 24
$-298.0K
Q3 24
$358.0K
Q2 24
$-35.8M
$-184.0K
Q1 24
$-36.0M
FCF Margin
DBVT
DBVT
ELSE
ELSE
Q4 25
Q3 25
-1173.5%
14.2%
Q2 25
-2316.5%
Q1 25
Q4 24
-12.4%
Q3 24
14.3%
Q2 24
-3084.0%
-8.3%
Q1 24
-2560.6%
Capex Intensity
DBVT
DBVT
ELSE
ELSE
Q4 25
Q3 25
4.2%
0.2%
Q2 25
2.2%
Q1 25
Q4 24
0.9%
Q3 24
0.2%
Q2 24
63.0%
1.2%
Q1 24
94.9%
0.0%
Cash Conversion
DBVT
DBVT
ELSE
ELSE
Q4 25
0.19×
Q3 25
1.90×
Q2 25
4.69×
Q1 25
Q4 24
-1.38×
Q3 24
1.52×
Q2 24
Q1 24
18.36×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons